| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 118.84× | 118.84× | 94.45× | 141.02× | 56.78× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.32× | 0.21× | 0.18× | −0.00× | −0.01× | ||
| 0.01× | 0.01× | 0.00× | 0.00× | 0.00× | ||
| 22.12× | 22.12× | 0.15× | −0.71× | −0.67× | ||
| 17.85× | 17.85× | −37.06× | −42.35× | −166.98× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 56.78 | 141.02 | 94.45 | 118.84 | 118.84 | |
| Working Capital Turnover | -0.01 | -0.00 | 0.18 | 0.21 | 0.32 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Cash Conversion (CFO/Net Income) | -0.67 | -0.71 | 0.15 | 22.12 | 22.12 | |
| CFO/EBITDA | -166.98 | -42.35 | -37.06 | 17.85 | 17.85 |